sur Moderna, Inc. (NASDAQ:MRNA)
Moderna to Announce Q1 2025 Financial Results in Early May
Moderna, Inc. has set plans to unveil its financial results for the first quarter of 2025. The announcement will occur on Thursday, May 1, 2025, accompanied by a live conference call and webcast scheduled for 8:00 a.m. ET. This event will also feature a corporate update.
The webcast of the call will be accessible via the "Events and Presentations" section on Moderna's website. It will remain archived and available about two hours post-conference and can be accessed for up to a year following the event.
Moderna is recognized for pioneering the mRNA medicine field, significantly impacting the development of therapies and vaccines across various health domains. The company is noted for its rapid vaccine development, including one of the earliest and most effective COVID-19 vaccines.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Moderna, Inc.